Paul Sherwin

1.9k total citations
33 papers, 908 citations indexed

About

Paul Sherwin is a scholar working on Neurology, Radiology, Nuclear Medicine and Imaging and Cellular and Molecular Neuroscience. According to data from OpenAlex, Paul Sherwin has authored 33 papers receiving a total of 908 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Neurology, 10 papers in Radiology, Nuclear Medicine and Imaging and 8 papers in Cellular and Molecular Neuroscience. Recurrent topics in Paul Sherwin's work include Medical Imaging Techniques and Applications (8 papers), Alzheimer's disease research and treatments (7 papers) and Neurological disorders and treatments (6 papers). Paul Sherwin is often cited by papers focused on Medical Imaging Techniques and Applications (8 papers), Alzheimer's disease research and treatments (7 papers) and Neurological disorders and treatments (6 papers). Paul Sherwin collaborates with scholars based in United States, United Kingdom and Spain. Paul Sherwin's co-authors include Adrian Smith, Christopher Buckley, Robert Penn, Eric Block, Igor D. Grachev, Johan Lilja, Rik Vandenberghe, Lennart Thurfjell, Roger Lundqvist and Robert J. Olsen and has published in prestigious journals such as Journal of the American Chemical Society, Neurology and Journal of Medicinal Chemistry.

In The Last Decade

Paul Sherwin

31 papers receiving 884 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Paul Sherwin United States	16	324	284	211	185	141	33	908
Göran Westerberg Sweden	22	86 0.3×	73 0.3×	174 0.8×	187 1.0×	110 0.8×	46	1.1k
Kerstin Heurling Sweden	18	354 1.1×	530 1.9×	230 1.1×	78 0.4×	141 1.0×	43	1.0k
Eric Triau Belgium	5	386 1.2×	465 1.6×	189 0.9×	48 0.3×	174 1.2×	10	738
H. G. Gemmell United Kingdom	19	358 1.1×	209 0.7×	580 2.7×	183 1.0×	203 1.4×	50	1.3k
J. Mark K. H. Wierda Netherlands	26	162 0.5×	88 0.3×	34 0.2×	98 0.5×	111 0.8×	76	1.8k
Mei-Ping Kung United States	17	106 0.3×	229 0.8×	251 1.2×	181 1.0×	60 0.4×	19	990
Marc S. Berridge United States	27	91 0.3×	180 0.6×	829 3.9×	67 0.4×	105 0.7×	82	1.9k
Robert Lew United States	24	119 0.4×	91 0.3×	198 0.9×	97 0.5×	100 0.7×	68	1.7k
Gill Farrar United Kingdom	20	892 2.8×	963 3.4×	452 2.1×	110 0.6×	338 2.4×	65	1.5k
Michal Figurski United States	13	458 1.4×	521 1.8×	59 0.3×	93 0.5×	108 0.8×	22	881

Countries citing papers authored by Paul Sherwin

Since Specialization

Citations

This map shows the geographic impact of Paul Sherwin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Sherwin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Sherwin more than expected).

Fields of papers citing papers by Paul Sherwin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul Sherwin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Sherwin. The network helps show where Paul Sherwin may publish in the future.

Co-authorship network of co-authors of Paul Sherwin

This figure shows the co-authorship network connecting the top 25 collaborators of Paul Sherwin. A scholar is included among the top collaborators of Paul Sherwin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul Sherwin. Paul Sherwin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hattori, Naoya, Paul Sherwin, & Gill Farrar. (2020). Initial Physician Experience with [¹⁸F]Flutemetamol Amyloid PET Imaging Following Availability for Routine Clinical Use in Japan. Journal of Alzheimer s Disease Reports. 4(1). 165–174. 4 indexed citations

Miki, Takami, Hiroyuki Shimada, Jae‐Seung Kim, et al.. (2017). Brain uptake and safety of Flutemetamol F 18 injection in Japanese subjects with probable Alzheimer’s disease, subjects with amnestic mild cognitive impairment and healthy volunteers. Annals of Nuclear Medicine. 31(3). 260–272. 10 indexed citations

Buckley, Christopher, et al.. (2016). Validation of an electronic image reader training programme for interpretation of [18F]flutemetamol β-amyloid PET brain images. Nuclear Medicine Communications. 38(3). 234–241. 50 indexed citations

Ikonomović, Miloš D., Christopher Buckley, Kerstin Heurling, et al.. (2016). Post-mortem histopathology underlying β-amyloid PET imaging following flutemetamol F 18 injection. Acta Neuropathologica Communications. 4(1). 130–130. 74 indexed citations

Thurfjell, Lennart, Johan Lilja, Roger Lundqvist, et al.. (2014). Automated Quantification of ¹⁸F-Flutemetamol PET Activity for Categorizing Scans as Negative or Positive for Brain Amyloid: Concordance with Visual Image Reads. Journal of Nuclear Medicine. 55(10). 1623–1628. 166 indexed citations

O’Brien, John T., Wolfgang H. Oertel, Ian G. McKeith, et al.. (2014). Is ioflupane I123 injection diagnostically effective in patients with movement disorders and dementia? Pooled analysis of four clinical trials. BMJ Open. 4(7). e005122–e005122. 30 indexed citations

Leinonen, Ville, Juha O. Rinne, Dean F. Wong, et al.. (2014). Diagnostic effectiveness of quantitative [18F]flutemetamol PET imaging for detection of fibrillar amyloid β using cortical biopsy histopathology as the standard of truth in subjects with idiopathic normal pressure hydrocephalus. Acta Neuropathologica Communications. 2(1). 46–46. 17 indexed citations

Heurling, Kerstin, Takami Miki, Hiroyuki Shimada, et al.. (2014). IC‐P‐017: BLINDED VISUAL EVALUATION AND QUANTITATIVE SUVR THRESHOLD CLASSIFICATION OF [18F]FLUTEMETAMOL PET IMAGES IN JAPANESE SUBJECTS. Alzheimer s & Dementia. 10(4S_Part_5). 1 indexed citations

Grosset, Donald G., Klaus Tatsch, Wolfgang H. Oertel, et al.. (2014). Safety Analysis of 10 Clinical Trials and for 13 Years After First Approval of Ioflupane ¹²³I Injection (DaTscan). Journal of Nuclear Medicine. 55(8). 1281–1287. 17 indexed citations

10.

Main, Michael L., Paul Grayburn, Roberto M. Lang, et al.. (2013). Effect of Optison on Pulmonary Artery Systolic Pressure and Pulmonary Vascular Resistance. The American Journal of Cardiology. 112(10). 1657–1661. 11 indexed citations

11.

Kupsch, Andreas, Nin Bajaj, Frederick L. Weiland, et al.. (2012). Impact of DaTscan SPECT imaging on clinical management, diagnosis, confidence of diagnosis, quality of life, health resource use and safety in patients with clinically uncertain parkinsonian syndromes: a prospective 1-year follow-up of an open-label controlled study. Journal of Neurology Neurosurgery & Psychiatry. 83(6). 620–628. 57 indexed citations

12.

Rinne, Juha O., Dean F. Wong, David A. Wolk, et al.. (2012). [18F]Flutemetamol PET imaging and cortical biopsy histopathology for fibrillar amyloid β detection in living subjects with normal pressure hydrocephalus: pooled analysis of four studies. Acta Neuropathologica. 124(6). 833–845. 62 indexed citations

13.

Kupsch, Andreas, Nin Bajaj, Frederick L. Weiland, et al.. (2012). Changes in Clinical Management and Diagnosis following DaTscan™ SPECT Imaging in Patients with Clinically Uncertain Parkinsonian Syndromes: A 12-Week Follow-Up Study. Neurodegenerative Diseases. 11(1). 22–32. 13 indexed citations

14.

Wong, Dean F., Abhay Moghekar, Daniele Rigamonti, et al.. (2012). An In Vivo Evaluation of Cerebral Cortical Amyloid with [18F]Flutemetamol Using Positron Emission Tomography Compared with Parietal Biopsy Samples in Living Normal Pressure Hydrocephalus Patients. Molecular Imaging and Biology. 15(2). 230–237. 32 indexed citations

15.

Rudnick, Michael R., Charles J. Davidson, Warren K. Laskey, Jane Stafford, & Paul Sherwin. (2008). Nephrotoxicity of iodixanol versus ioversol in patients with chronic kidney disease: The Visipaque Angiography/Interventions with Laboratory Outcomes in Renal Insufficiency (VALOR) Trial. American Heart Journal. 156(4). 776–782. 76 indexed citations

16.

Sherwin, Paul, et al.. (2005). Contrast Dose-to-Creatinine Clearance Ratio as a Potential Indicator of Risk for Radiocontrast-Induced Nephropathy. Investigative Radiology. 40(9). 598–603. 40 indexed citations

17.

Hu, Yuefei, Paul Sherwin, & Douglas F. Covey. (1995). Synthesis of (17R)- and (17S)-17-hydroxy-14, 15-secoandrost-4-en-15-yn-3-one and the X-ray crystal structure of the (17S)-diastereomer. Steroids. 60(6). 491–496. 2 indexed citations

18.

Sherwin, Paul, et al.. (1994). Safety, Tolerance, and Pharmacokinetics of High Doses of Gadodiamide Injection, a Nonionic Magnetic Resonance Imaging Contrast Agent. Academic Radiology. 1. S2–S9. 5 indexed citations

19.

Sherwin, Paul, et al.. (1989). Effects of steroid D-ring modification on suicide inactivation and competitive inhibition of aromatase by analogs of androsta-1,4-diene-3,17-dione. Journal of Medicinal Chemistry. 32(3). 651–658. 24 indexed citations

20.

Sherwin, Paul & Robert M. Coates. (1982). Stereospecificity of the oxidation of ent-kauren-19-ol to ent-kaurenal by a microsomal enzyme preparation from Marah macrocarpus. Journal of the Chemical Society Chemical Communications. 1013–1013. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact